Barclays PLC Exact Sciences Corp Transaction History

Barclays PLC

$377 Billion
Q3 2024

A detailed history of Barclays PLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Barclays PLC holds 209,772 shares of EXAS stock, worth $12.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

209,772

Previous 209,772 -0.0%

Holding current value

$12.5 Million

Previous $14.3 Million -0.0%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	SELL	$42.43 - $70.83 $4.05 Million - $6.77 Million	-95,512 Reduced 31.29%	209,772 $14.3 Million
Q2 2024 Aug 14, 2024	BUY	$41.33 - $74.26 $3.24 Million - $5.82 Million	78,345 Added 34.52%	305,284 $12.9 Million
Q1 2024 May 15, 2024	SELL	$56.27 - $73.77 $825,874 - $1.08 Million	-14,677 Reduced 6.07%	226,939 $15.7 Million
Q4 2023 Feb 15, 2024	BUY	$59.06 - $75.72 $2.45 Million - $3.14 Million	41,529 Added 20.76%	241,616 $17.9 Million
Q3 2023 Nov 07, 2023	BUY	$65.94 - $99.04 $1.14 Million - $1.71 Million	17,243 Added 9.43%	200,087 $13.7 Million
Q2 2023 Aug 03, 2023	SELL	$62.68 - $95.05 $1.14 Million - $1.73 Million	-18,241 Reduced 9.07%	182,844 $17.2 Million
Q1 2023 May 04, 2023	SELL	$47.19 - $70.77 $4.24 Million - $6.36 Million	-89,865 Reduced 30.89%	201,085 $13.6 Million
Q4 2022 Feb 13, 2023	SELL	$30.35 - $53.15 $297,035 - $520,179	-9,787 Reduced 3.25%	290,950 $14.4 Million
Q3 2022 Nov 03, 2022	BUY	$31.97 - $49.37 $1.59 Million - $2.45 Million	49,589 Added 19.74%	300,737 $9.77 Million
Q2 2022 Aug 12, 2022	BUY	$35.61 - $76.23 $1.62 Million - $3.47 Million	45,576 Added 22.17%	251,148 $9.89 Million
Q1 2022 May 16, 2022	SELL	$57.56 - $82.54 $791,680 - $1.14 Million	-13,754 Reduced 6.27%	205,572 $14.4 Million
Q4 2021 Feb 14, 2022	SELL	$72.5 - $100.68 $389,252 - $540,550	-5,369 Reduced 2.39%	219,326 $17.1 Million
Q3 2021 Nov 09, 2021	BUY	$90.24 - $124.05 $8.34 Million - $11.5 Million	92,388 Added 69.83%	224,695 $21.4 Million
Q2 2021 Aug 13, 2021	BUY	$93.66 - $139.27 $3.9 Million - $5.8 Million	41,628 Added 45.91%	132,307 $16.4 Million
Q1 2021 May 13, 2021	BUY	$116.57 - $155.01 $955,874 - $1.27 Million	8,200 Added 9.94%	90,679 $11.9 Million
Q4 2020 Feb 11, 2021	BUY	$99.61 - $142.12 $1.12 Million - $1.6 Million	11,246 Added 15.79%	82,479 $10.9 Million
Q3 2020 Nov 12, 2020	BUY	$72.92 - $102.01 $32,157 - $44,986	441 Added 0.62%	71,233 $7.26 Million
Q2 2020 Aug 12, 2020	SELL	$55.75 - $92.75 $1.89 Million - $3.14 Million	-33,838 Reduced 32.34%	70,792 $6.15 Million
Q1 2020 May 13, 2020	SELL	$37.9 - $104.44 $2.28 Million - $6.29 Million	-60,239 Reduced 36.54%	104,630 $6.07 Million
Q4 2019 Feb 10, 2020	BUY	$77.66 - $99.74 $3.24 Million - $4.16 Million	41,721 Added 33.88%	164,869 $15.2 Million
Q3 2019 Nov 14, 2019	BUY	$90.37 - $122.49 $6.98 Million - $9.45 Million	77,188 Added 167.95%	123,148 $11.1 Million
Q2 2019 Aug 14, 2019	SELL	$89.51 - $118.04 $5.01 Million - $6.61 Million	-56,003 Reduced 54.92%	45,960 $5.43 Million
Q1 2019 May 15, 2019	SELL	$61.98 - $96.5 $691,758 - $1.08 Million	-11,161 Reduced 9.87%	101,963 $8.83 Million
Q4 2018 Feb 14, 2019	BUY	$56.04 - $82.66 $4.23 Million - $6.23 Million	75,419 Added 200.02%	113,124 $7.14 Million
Q3 2018 Nov 14, 2018	SELL	$48.29 - $80.6 $10.2 Million - $17 Million	-210,563 Reduced 84.81%	37,705 $2.98 Million
Q2 2018 Aug 14, 2018	BUY	$37.84 - $69.96 $5.23 Million - $9.66 Million	138,137 Added 125.43%	248,268 $14.8 Million
Q1 2018 May 15, 2018	BUY	$39.82 - $57.53 $1.22 Million - $1.76 Million	30,602 Added 38.48%	110,131 $4.44 Million
Q4 2017 Feb 14, 2018	BUY	$46.49 - $60.51 $3.56 Million - $4.64 Million	76,603 Added 2618.01%	79,529 $4.18 Million
Q3 2017 Nov 14, 2017	BUY	$37.05 - $47.12 $108,408 - $137,873	2,926	2,926 $137,000

Others Institutions Holding EXAS

# of Institutions

673

Shares Held

162M

Call Options Held

2.58M

Put Options Held

2.19M

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.5B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account